Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at...
Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study
About this item
Full title
Author / Creator
Tsavaris, Nicolas , Kosmas, Christos , Skopelitis, Helias , Papadoniou, Nicitas , Polyzos, Aristidis , Zografos, George , Adoniou, Efstathios , Gryniatsos, John , Felekouras, Evangelos , Zacharakis, Michalis , Sigala, Francheska , Bacoyiannis, Christos , Papastratis, George and Papalambros, Efstathios
Publisher
Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
The purpose of the present study was to evaluate the differences in the sequence of administration of 5-fluorouracil (5-FU)/leucovorin (LV) followed by irinotecan (CPT-11), or CPT-11 followed by 5-FU/LV in advanced colorectal cancer (ACC).
Chemotherapy-naïve patients with ACC were allocated to the following treatment groups: group A, a bolus of...
Alternative Titles
Full title
Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223265057
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223265057
Other Identifiers
ISSN
0009-3157
E-ISSN
1421-9794
DOI
10.1159/000102583
